Pharmaceutical formulation
US12370189B2 · kind B2 · utility
0Cited by
135References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2021 |
| Grant date | Jul 29, 2025 |
| Priority date | — |
| Expiry date | Oct 22, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin, naproxen and at least one further active which is selected to be an antitussive, a decongestant or an antihistamine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.